Screen: 19
Kristin Hsieh, MD
Icahn School of Medicine at Mount Sinai
New York, NY
Table 1 * Column percentage is reported. † 1 completed a pediatric proton therapy and neuro-oncology fellowship ‡ 2 completed immunotherapy-related fellowships, 1 gynecology fellowship, 1 epidemiology fellowship, 1 health policy, and 1 genomics fellowship § Row percentage is reported unless otherwise noted. ¶ 6 participants are still fellows, so the percentage is calculated with a denominator of 16. # Individuals who have their own labs, are in a lab, or have investigated clinical trials are included.
Fellowship type | # (%*) of participants | # (%§) of participants who are practicing radiation oncologists in academic settings | # (%§) of participants whose current employment website includes the focus of their fellowship as an area of focus or clinical expertise |
Research | 22 (28.2%) | 14 (87.5%¶) | 11# (68.8%¶) |
Protons | 17 (21.8%) | 13 (76.5%) | 8 (47.1%) |
Brachytherapy | 14 (17.9%) | 10 (71.4%) | 9 (64.3%) |
Proton/Pediatric | 5† (6.4%) | 4 (80.0%) | 9 (60.0%) |
SRS | 4 (5.1%) | 1 (25.0%) | 0 (0.0%) |
Clinical (not otherwise specified) | 4 (5.1%) | 3 (75.0%) | N/a |
Palliative | 3 (3.8%) | 1 (33.3%) | 1 (33.3%) |
Not specified | 3 (3.8%) | 2 (66.7%) | N/a |
Other | 6‡ (7.7%) | 2 (33.3%) | N/a |